Low-grade systemic inflammation, a key driver of T2DM progression, can be assessed via inflammatory cytokines such as IL-1β, IL-6 and TNF-α [104], and vaspin seems to reduce the expression of all of them [32]. This evidence concerns the gene TNF and type 2 diabetes mellitus.